Federation des caisses Desjardins du Quebec’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-200
Closed -$5.9K 2620
2021
Q3
$5.9K Buy
+200
New +$5.9K ﹤0.01% 2194